Schrödinger (SDGR) 2025 Conference June 04, 2025 01:25 PM ET Speaker0 Thank you. Good afternoon. I'm Michael Yee, senior biotechnology analyst at Jefferies, and I'm really pleased to have members of the executive team of Schrodinger up here. I believe in order here down on the far left there is Karen Akinsaya. Many of you know her. She's President of R and D at Therapeutics. And we're going talk a little bit about some data on MALT1 and what could be coming in the pipeline. Obviously, Margaret Nugen, CMO. S ...